Synta Pharmaceuticals Announces Upcoming Oral Presentations On Hsp90-Inhibitor Drug Conjugate (HDC) Platform

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the following HDC oral presentations are scheduled to take place:

Help employers find you! Check out all the jobs and post your resume.